<
Tongrentang was bidded in the bidding of some provinces by ultra -low -priced bids
Release time: 2010-07-12 & nbsp & nbsp & nbsp Source:
     Tongrentang of 340 History,It is painful and experienced.,Ancient training of youthful knowledge "。 
    "First Financial Daily" confirmed from multiple parties,Many companies represented by Tongrentang,At present, the basic drug supply of countries in many provinces has been withdrawn from many provinces,Low price or even ultra -low -priced bidding,It is an important reason for forcing these companies to "out"。 
    Tongrentang helplessly exit 
    As an important part of the new medical reform,A total of 307 varieties of national basic drug directory promulgated in August 2009,Among them, 102 Chinese medicine varieties。Due to the obvious advantages of quality brand,The family of Tongrentang has 42 varieties,Occupy 40 % of the Chinese medicine directory。 
    Not only that,Beyond the original industrial stake online sports bettingproduction stake online sports bettingvariety,According to the new medical reform, the idea of ​​compression of circulation links,Tongrentang also hoped to this system more。 
    March this year,Mei Qun, the general manager of Tongrentang Group, said,Under the background of implementing the basic drug system nationwide,Tongrentang is actively bidding for basic drug distribution rights,and proposed a plan to double the operating indicators within 5 years,At that time, Tongrentang sales will reach 20 billion yuan。 
    But with the bidding of basic drugs in various places, it has been started one after another,The problems in which are gradually exposed,The pressure of price reduction has also begun to let the company gradually feel the other side of the bidding of basic drugs。 
    "Tongrentang has withdrawn from many provinces in the near future,It is because there is no way to meet the requirements of low price。"Yu Mingde, chairman of the China Medical Enterprise Management Association,Bidding in many places does not ask the price at all,First cut 15%、20%of the price to talk about,This violation of the market and scientific operation method,Let some companies even force the lowest cost line。 
    "I listen to Tongsang Said,Many bidding prices can not even buy medicinal materials,',Those medicines who are obscure to the quality of poor quality,The company must bear huge brand risks,Under the current circumstances, I have to be forced to exit。"Yu Mingde further pointed out,If the current bidding price is not reversed,Perhaps it will lead to more "Infacions of Switch Outstanding"。 
    This newspaper was interviewed when I interviewed Tongrentang yesterday,The other party stake betting appdid not Stake Sports Bettingrespond positively,But the personnel of the internal price management department told reporters,Exit some market,"It seems like I heard that there is such a thing。” 
    Behind the low price 
    In the Chinese medicine industry,"Good medicinal materials,Drugs are good "is not a simple promotional advertisement,but a truth that has verified the direct related to medicinal materials and efficacy for thousands of years。 
    But on the other hand,Also because of the high dependence on medicinal materials,Many Chinese medicine companies are subject to weather、output,Even market speculative behavior,Costs are often difficult to control。 
    Fang Guanghong, deputy general manager of Guangyao Baiyunshan, disclosed in an interview with this newspaper,On the one hand, the cost rises crazy,On the one hand, bidding is sharply bargain,Baiyunshan has been "carried" on the cost line this year。He told reporters,Taking Baiyun Mountain and Yellow's two main products compound Dan Dan Ginseng and Banlangen Granules as examples,The annual sales of these two varieties are above 500 million yuan,But due to the weather in the south this year and market speculative behavior,The transaction price of the raw material in the compound Danshen tablets,Even after governance, it remains up to 500 yuan/kg,More than 10 times more than last year,The cost of this variety increased by about 100 million yuan; and the cost of the Banlangen granules,Not only raw material board Lantan soared,Even the unit price of auxiliary materials white sugar has been raised from the original 3000 yuan/ton to 6000 yuan/ton。 
    Zheng Hong, Director of the Division of the stake sports betting appMinistry Stake Sports Bettingof Health's Drug Policy and Basic Drug System, once publicized the price reduction of the bidding price,The average price of basic drugs is about 10%,At the same time, basic drugs implement a zero -difference rate sales at the grassroots level,Cancel 15%drug bonus。
    The two add up, the price is at least 25%. 
    Some people in the industry said,Dested,25%is just the average price reduction amplitude of basic drugs,The price reduction of some specific drugs will even be more。 
    "There are more than 30 varieties in Shuanghe enter the basic drug directory,Only 3 are really produced now,Not unwilling to do,but the price of bidding in many places,Normal methods can't do it at all,We dare not do it。"A person close to Beijing Shuanghe told reporters。 
    Compared to those companies that are forced to withdraw from the national basic drug directory team,The more realistic problem is,Those medicines that have won at ultra -low price,How did they produce? Are they guaranteed quality? 
    Dested,Relevant regulatory authorities have begun to notice low -cost issues in bidding in various places。"We are studying the" Base Basis of the Principles of National Basic Drug Price ","Guo Jianying, Director of the Price Division of the National Development and Reform Commission, publicly expressed it on the 7th on the 7th,The National Development and Reform Commission discovered after the basic drug pricing last year,There are contradictions in the price of drugs。He gives an example,0.92 yuan/branch penicillin,The lowest price of bidding purchase can reach 0.30 yuan/support,Dested,This phenomenon is not uncommon in the current bidding。My stake betting appData stake betting appshowed by the National Development and Reform Commission,In the national basic drug directory,Various varieties with less than 1 yuan have accounted for 60%。 
    Pharmaceuticals with obvious price reductions in the bidding link,At present, there seems to be virtual high components in the consumption link,How to ensure its normal supply and guarantee its quality level,Obviously still a lot of challenges。